Dabigatran Etexilate
Back to searchMolecule Structure
Scientific Name
Dabigatran Etexilate
Description of the Drug
Dabigatran etexilate is an anticoagulant used for the prevention of venous thromboembolic events or stroke in patients with recent elective hip or knee replacement surgery and atrial fibrillation.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06695
http://www.drugbank.ca/drugs/DB06695
Brand Name(s)
Pradaxa
Company Owner(s)
Boehringer Ingelheim Pharmaceuticals Inc, Alkem Laboratories Ltd, Hetero Labs Ltd Unit Iii
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Thrombin | SINGLE PROTEIN | INHIBITOR | CHEMBL204 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL505829 | |||
PharmGKB | PA165958369 | |||
Human Metabolome Database | HMDB0015641 | |||
DrugBank | DB06695 | |||
PubChem: Thomson Pharma | 17383903 | 14814262 | 49701786 | |
PubChem | 6445226 | 213023 | 135565674 | 9578572 |
LINCS | LSM-45249 | |||
Nikkaji | J2.566.951G | |||
BindingDB | 50432209 | |||
EPA CompTox Dashboard | DTXSID4057681 | |||
DrugCentral | 776 | |||
Brenda | 40386 | 167472 | ||
Guide to Pharmacology | 6379 | |||
rxnorm | DABIGATRAN ETEXILATE | DABIGATRAN ETEXILATE MESYLATE | PRADAXA | |
ChEBI | 70746 | |||
ZINC | ZINC000003943279 |